Marco Pieroni

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Shichun Lun, Haidan Guo, Oluseye K. Onajole et al. · Nature Communications · 2013 · 151 citations · Full text

Pulmonary Tuberculosis, Health Sciences, Medicine +11

Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains

Oluseye K. Onajole, Marco Pieroni, Suresh K. Tipparaju et al. · Journal of Medicinal Chemistry · 2013 · 123 citations

From Serendipity to Rational Antituberculosis Drug Discovery of Mefloquine-Isoxazole Carboxylic Acid Esters

Jialin Mao, Hai Yuan, Yuehong Wang et al. · Journal of Medicinal Chemistry · 2009 · 106 citations

Substituted <i>N</i>-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery

Elisa Azzali, Diana Machado, Amit Kaushik et al. · Journal of Medicinal Chemistry · 2017 · 79 citations

In Pursuit of Natural Product Leads: Synthesis and Biological Evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4-carboxylic acid (A-33853) and Its Analogues: Discovery of <i>N</i>-(2-Benzoxazol-2-ylphenyl)benzamides as Novel Antileishmanial Chemotypes

Suresh K. Tipparaju, Sipak Joyasawal, Marco Pieroni et al. · Journal of Medicinal Chemistry · 2008 · 74 citations